Naloxegol for treating opioid‑induced constipation

  • Technology appraisal guidance
  • TA345
  • Published: 

History

Constipation (opioid-induced) - naloxegol: equality impact assessment - guidance development

Constipation (opioid-induced) - naloxegol: final appraisal determination

Constipation (opioid-induced) - naloxegol: final scope

Constipation (opioid induced) - naloxegol: final matrix

Constipation (opioid induced) - naloxegol: equality impact assessment - scoping

Constipation (opioid induced) - naloxegol: NICE's response to C&C comments on the draft scope and provisional matrix

Constipation (opioid-induced) - naloxegol: draft scope for consultation (pre-referral) - September 2013

Constipation (opioid-induced) - naloxegol: provisional matrix (pre-referral) - September 2013